哮喘患儿布地奈德雾化吸入治疗的临床研究

Research on budesonide aerosol inhalation in treatment of children with asthma

  • 摘要: 目的 探讨布地奈德雾化吸入对哮喘患儿免疫功能与不良反应的影响。 方法 采用简单随机抽样法选取100例哮喘患儿作为研究对象,以抽签法分为2组,每组50例。对照组采用常规治疗,研究组采用布地奈德雾化吸入治疗,比较2组炎症指标、肺功能指标、免疫功能指标水平及不良反应发生情况。 结果 治疗后,研究组白细胞介素-4(IL-4)、白细胞介素-6(IL-6)水平显著低于对照组(P<0.05), γ干扰素(IFN-γ)水平显著高于对照组(P<0.05); 研究组用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、25%肺活量最大呼气流量(MEF25)水平显著高于对照组(P<0.05); 研究组CD4+、CD4+/CD8+水平显著高于对照组(P<0.05), CD8+水平显著低于对照组(P<0.05); 研究组不良反应发生率为4.00%, 对照组为8.00%, 差异无统计学意义(P>0.05)。 结论 将布地奈德雾化吸入应用于哮喘患儿的治疗中,可减轻患儿炎症反应,改善肺功能、免疫功能,且不良反应少。

     

    Abstract: Objective To investigate the effects of budesonide aerosol inhalation on immune function and adverse reactions in children with asthma. Methods A simple random sampling method was used to select 100 asthmatic children, and they were divided into two groups according to lottery method. The control group(n=50)received routine treatment, and the study group(n=50)received budesonide atomization inhalation. The levels of inflammation as well as lung function indexes, immune function indexes and adverse reactions were compared between the two groups. Results After treatment, interleukin-4(IL-4)and interleukin-6(IL-6)in the study group were lower than those in the control group, and interferon γ(IFN-γ)was significantly higher that in the control group(P<0.05); forced vital capacity(FVC), forced expiratory volume in 1 second(FEV1), 25% maximum expiratory capacity(MEF25)in the study group were higher than those in the control group(P<0.05); the levels of CD4+ and CD4+/CD8+ in the study group were higher, and level of CD8+ was lower than that in the control group(P<0.05); the incidence of adverse reactions was 4.00% in the study group and 8.00% in the control group, but there was no significant difference(P>0.05). Conclusion Budesonide aerosol inhalation in the treatment of children with asthma can reduce inflammation reaction, improve lung function and immune function, and reduce adverse reactions.

     

/

返回文章
返回